SMED Sharps Compliance

Sharps Compliance Corp. engages in the provision of healthcare waste management services including medical, pharmaceutical, and hazardous. It focuses on developing management solutions for medical waste and unused dispensed medications generated by small and medium quantity generators. The company was founded in November 1992 and is headquartered in Houston, TX.
Company profile
Ticker
SMED
Exchange
Website
CEO
David P. Tusa
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
Former names
US MEDICAL SYSTEMS INC
SEC CIK
Corporate docs
IRS number
742657168
SMED stock data
()
News
Stifel Maintains Buy on Sharps Compliance, Raises Price Target to $16
30 Mar 21
Stocks That Hit 52-Week Highs On Wednesday
17 Feb 21
Stocks That Hit 52-Week Highs On Friday
12 Feb 21
Stocks Making New 52-Week Highs/Lows For Wednesday, Feb. 10, 2021 (Via Benzinga Pro's Signals Tool)
10 Feb 21
Stocks That Hit 52-Week Highs On Monday
8 Feb 21
Press releases
Sharps Compliance to Participate at the ROTH Virtual Conference
3 Mar 21
Sharps Compliance Expands Company-Owned Route-Based Services to Arizona, Colorado, New Mexico and Utah
2 Mar 21
Sharps Compliance Corp. to Host Earnings Call
28 Jan 21
Sharps Compliance Reports Fiscal 2021 Second Quarter Results
28 Jan 21
Sharps Compliance Announces Second Quarter Fiscal 2021 Conference Call and Webcast
14 Jan 21
Calendar
3 Feb 21
11 Apr 21
30 Jun 21
Financial summary
Quarter (USD) |
Dec 20 | Sep 20 | Jun 20 | Mar 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) |
Jun 20 | Jun 19 | Jun 18 | Jun 17 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Financial data from company earnings reports.
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
9 Feb 21 | John W Dalton | Common Stock | Sell | Dispose S | No | No | 13.945 | 2,000 | 27.89K | 845,482 |
9 Feb 21 | John W Dalton | Common Stock | Sell | Dispose S | No | No | 13.93 | 3,000 | 41.79K | 847,482 |
8 Feb 21 | John W Dalton | Common Stock | Sell | Dispose S | No | No | 14.39 | 100 | 1.44K | 850,482 |
8 Feb 21 | John W Dalton | Common Stock | Sell | Dispose S | No | No | 14.38 | 4,900 | 70.46K | 850,582 |
3 Feb 21 | John W Dalton | Common Stock | Sell | Dispose S | No | No | 12.65 | 2,600 | 32.89K | 855,482 |
3 Feb 21 | John W Dalton | Common Stock | Sell | Dispose S | No | No | 12.59 | 4,600 | 57.91K | 858,082 |
3 Feb 21 | John W Dalton | Common Stock | Sell | Dispose S | No | No | 12.5471 | 3,500 | 43.91K | 862,682 |
3 Feb 21 | John W Dalton | Common Stock | Sell | Dispose S | No | No | 12.5135 | 6,500 | 81.34K | 866,182 |
2 Feb 21 | Diana P Diaz | Common Stock | Sell | Dispose S | No | No | 12.63 | 63,235 | 798.66K | 8,575 |
2 Feb 21 | Diana P Diaz | Common Stock | Option exercise | Aquire M | No | No | 4.3 | 63,235 | 271.91K | 71,810 |
Institutional ownership Q4 2020
Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.
42.7% owned by funds/institutions
13F holders |
Current |
---|---|
Total holders | 68 |
Opened positions | 11 |
Closed positions | 11 |
Increased positions | 24 |
Reduced positions | 20 |
13F shares |
Current |
---|---|
Total value | 89.14M |
Total shares | 7.06M |
Total puts | 0 |
Total calls | 36.5K |
Total put/call ratio | – |
Largest owners |
Shares | Value |
---|---|---|
Wasatch Advisors | 934.01K | $8.83M |
BLK Blackrock | 788.65K | $7.45M |
Royce & Associates | 655.1K | $6.19M |
Vanguard | 624.24K | $5.9M |
Granahan Investment Management | 611.97K | $5.78M |
Renaissance Technologies | 405.95K | $3.84M |
Millrace Asset | 395.74K | $3.74M |
Uniplan Investment Counsel | 337.82K | $3.19M |
STT State Street | 211.64K | $2M |
Geode Capital Management | 195.13K | $1.84M |
Financial report summary
?Competition
StericycleRisks
- We may be unable to manage our growth effectively.
- If the flu related business of our customers decreases, the revenues generated by our business could decrease.
- Our quarterly results may fluctuate significantly.
- Our business is dependent on a small number of customers. To the extent we are not successful in winning additional business mandates from our government and commercial customers or attracting new customers, our results of operations and financial condition would be adversely affected.
- The loss of our senior executives could affect our ability to manage the business profitability.
- The recent COVID-19 pandemic could have an adverse effect on our operations, results of operations, cash flows and financial condition
- Risks associated with our acquisition strategy could adversely affect our operating results.
- Aggressive pricing by existing competitors and the entrance of new competitors could drive down our profits and slow its growth.
- The lack of customer long-term volume commitments could adversely affect the Company’s profits and future growth.
- The Company is subject to extensive and costly federal, state and local laws, and existing or future regulations may restrict the Company’s operations, increase our costs of operations and subject us to additional liability.
- The inability of the Company to operate its treatment facilities would adversely affect its operations
- The handling, transportation and disposal or treatment of regulated waste carries with it the risk of personal injury to employees and others.
- Increases in transportation costs may adversely affect our business and results of operation.
- Restrictions in our Credit Agreement could adversely affect our business, financial condition, results of operations and value of our securities.
- An inability to win additional government contracts could have a material adverse effect on our operations and adversely affect our future revenue.
- As a government contractor, we are subject to extensive government regulation, and our failure to comply with applicable regulations could subject us to penalties that may restrict our ability to conduct our business.
- The possibility of postal work interruptions and restrictions on shipping through the mail would adversely affect the disposal or treatment element of the Company’s business and have an adverse effect on our operations, results of operations and financial condition.
- The Company’s stock has experienced, and may continue to experience, low trading volume and price volatility.
- We are subject to the reporting requirements of federal securities laws, and compliance with such requirements can be expensive and may divert resources from other projects, thus impairing our ability to grow.
- If we fail to establish and maintain an effective system of internal control, we may not be able to report our financial results accurately or to prevent fraud. An inability to report and file our financial results accurately and timely could harm our reputation and adversely impact the trading price of our common stock.
- We may be subject to information technology system failures, network disruptions and breaches in data security.
Management Discussion
- Total revenues for the fiscal year ended June 30, 2020 of $51.1 million increased by $6.8 million, or 15.4%, from the total revenues for the fiscal year ended June 30, 2019 of $44.3 million. The increase in revenue is mainly due to increased billings in the Retail, Home Health Care, Assisted Living, Professional and Pharmaceutical Manufacturer market. The increase in billings is partially offset by current year deferred revenue net of product returns on sales in prior periods. Billings by market are as follows (in thousands):
- *Represents the net impact of the revenue recognition adjustments to arrive at reported generally accepted accounting principles (“GAAP”) revenue. Customer billings include all invoiced amounts associated with products shipped or services rendered during the period reported. GAAP revenue includes customer billings as well as numerous adjustments necessary to reflect, (i) the deferral of a portion of current period sales, (ii) recognition of certain revenue associated with product returned for treatment and destruction and (iii) provisions for certain product returns and discounts to customers which are accounted for as reductions in sales in the same period the related sales are recorded. See Note 2 “Summary of Significant Accounting Policies” in “Notes to Consolidated Financial Statements”.
- (1)The Company’s other products include IV poles, accessories, containers, asset return boxes and other miscellaneous items.
Content analysis
?
Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
category, committed, consideration, modification, Nesquehoning, obligation, property, satisfying, transaction, wwith
Removed:
maturity, modified, relationship
Financial reports
10-Q
2021 Q2
Quarterly report
3 Feb 21
10-Q
2021 Q1
Quarterly report
4 Nov 20
10-K
2020 FY
Annual report
26 Aug 20
10-Q
2020 Q3
Quarterly report
5 May 20
10-Q
2020 Q2
Quarterly report
4 Feb 20
10-Q
2020 Q1
Quarterly report
30 Oct 19
10-K
2019 FY
Annual report
28 Aug 19
10-Q
2019 Q3
Quarterly report
1 May 19
10-Q
2019 Q2
Quarterly report
30 Jan 19
10-Q
2019 Q1
Quarterly report
1 Nov 18
Current reports
8-K
Departure of Directors or Certain Officers
8 Apr 21
8-K
Sharps Compliance Announces Appointment of Pat Mulloy, Veteran CEO of Long-Term and Senior Care Businesses, to Board of Directors
9 Feb 21
8-K
Sharps Compliance Reports Fiscal 2021 Second Quarter Results
28 Jan 21
8-K
Entry into a Material Definitive Agreement
22 Jan 21
8-K
Other Events
11 Jan 21
8-K
Entry into a Material Definitive Agreement
31 Dec 20
8-K
Departure of Directors or Certain Officers
20 Nov 20
8-K
Sharps Compliance Reports Fiscal 2021 First Quarter Results
27 Oct 20
8-K
Sharps Compliance Reports Fiscal 2020 Fourth Quarter Results
19 Aug 20
8-K
Sharps Compliance Appoints Adrian W. Burke as Senior Vice President of Operations; Announces John G. Elkins as Senior
1 Jul 20
Registration and prospectus
S-8
Registration of securities for employees
23 Nov 14
S-8
Registration of securities for employees
21 Nov 10
424B4
Prospectus supplement with pricing info
9 Dec 09
FWP
Free writing prospectus
7 Dec 09
S-3/A
Shelf registration (amended)
7 Dec 09
S-3/A
Shelf registration (amended)
7 Dec 09
S-3/A
Shelf registration (amended)
30 Nov 09
S-3/A
Shelf registration (amended)
24 Nov 09
S-3
Shelf registration
11 Nov 09
8-A12B
Registration of securities on exchange
22 Mar 09
Proxies
DEF 14A
Definitive proxy
7 Oct 20
DEF 14A
Definitive proxy
9 Oct 19
DEF 14A
Definitive proxy
3 Oct 18
PRE 14A
Preliminary proxy
20 Sep 18
DEF 14A
Definitive proxy
3 Oct 17
DEF 14A
Definitive proxy
4 Oct 16
DEF 14A
Definitive proxy
30 Sep 15
DEFR14A
Revised proxy
27 Oct 14
DEF 14A
Definitive proxy
30 Sep 14
DEF 14A
Definitive proxy
1 Oct 13
Other
UPLOAD
Letter from SEC
3 Mar 13
CORRESP
Correspondence with SEC
28 Feb 13
CORRESP
Correspondence with SEC
26 Feb 13
UPLOAD
Letter from SEC
14 Feb 13
CT ORDER
Confidential treatment order
6 Jul 10
UPLOAD
Letter from SEC
28 Jun 10
CORRESP
Correspondence with SEC
24 Jun 10
CORRESP
Correspondence with SEC
13 Jun 10
CORRESP
Correspondence with SEC
4 May 10
UPLOAD
Letter from SEC
20 Apr 10
Ownership
SC 13G/A
SHARPS COMPLIANCE / WASATCH ADVISORS ownership change
21 Feb 21
3
SHARPS COMPLIANCE / William Patrick Mulloy II ownership change
16 Feb 21
SC 13G
SHARPS COMPLIANCE / WASATCH ADVISORS ownership change
11 Feb 21
4
SHARPS COMPLIANCE / JOHN W DALTON ownership change
10 Feb 21
4
SHARPS COMPLIANCE / JOHN W DALTON ownership change
4 Feb 21
4
SHARPS COMPLIANCE / JOHN W DALTON ownership change
3 Feb 21
4
SHARPS COMPLIANCE / Diana P Diaz ownership change
3 Feb 21
4
SHARPS COMPLIANCE / JOHN W DALTON ownership change
17 Dec 20
4
SHARPS COMPLIANCE / PARRIS H HOLMES JR ownership change
17 Dec 20
4
SHARPS COMPLIANCE / JOHN W DALTON ownership change
16 Dec 20
Transcripts
2021 Q2
Earnings call transcript
29 Jan 21
2021 Q1
Earnings call transcript
27 Oct 20
2020 Q4
Earnings call transcript
19 Aug 20
2020 Q3
Earnings call transcript
29 Apr 20
2020 Q2
Earnings call transcript
28 Jan 20
2020 Q1
Earnings call transcript
23 Oct 19
2019 Q4
Earnings call transcript
21 Aug 19
2019 Q3
Earnings call transcript
24 Apr 19
2019 Q2
Earnings call transcript
23 Jan 19
2019 Q1
Earnings call transcript
24 Oct 18